Catyalyst Pharmaceutical Partners (CPRX) Cuts Q2 Loss by 1c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 --0%
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) reported Q2 EPS of ($0.06), versus ($0.07) reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- IDW Media Holdings, Inc. (IDWM) Misses Q1 EPS by 56c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
